)
)
Contineum Therapeutics Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 11,000+ public companies
Latest reports from Contineum Therapeutics Inc
Access all reports
Contineum Therapeutics Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of novel, oral small molecule therapies. The company focuses on treatments for neuroscience, inflammation, and immunology (NI&I) conditions that have significant unmet medical needs. Contineum is headquartered in San Diego, California, and its shares are listed on the NASDAQ.
Latest articles
)
Under the Hood: AutoZone's Blueprint for Retail Excellence
An in-depth look at the largest aftermarket auto parts retailer in the U.S., its philosophy, and masterful capital allocation.
19 Dec 2024
)
Lessons from Gautam Baid: Mastering Simplicity and Compounding
Gautam Baid's journey of compounding wisdom, investing simplicity, and lifelong learning – insights to transform your financial and personal growth.
13 Dec 2024
)
Rocket Lab: Breaking Ground in Space
Rocket Lab has been one of the pioneers in the commercial aerospace industry, with numerous satellite launches and space system applications.
9 Dec 2024
Ticker symbol
CTNM
Country
🇺🇸 United States